Detalhe da pesquisa
1.
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Signal Transduct Target Ther
; 8(1): 20, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596779
2.
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.
Signal Transduct Target Ther
; 7(1): 172, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665745
3.
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2.
Cell Discov
; 8(1): 17, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169113
4.
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Elife
; 112022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004719
5.
[Application of Excel Visual Basic for efficiently complete statistic analysis].
Zhonghua Liu Xing Bing Xue Za Zhi
; 26(12): 995-8, 2005 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-16676599
6.
[Epidemiology of communicable diseases in Huangpu District, Shanghai City, 1996--2002].
Zhonghua Liu Xing Bing Xue Za Zhi
; 25(8): 730, 2004 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-15555407